These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2574687)

  • 21. Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
    Lau YS; Trobough KL; Crampton JM; Wilson JA
    Gen Pharmacol; 1990; 21(2):181-7. PubMed ID: 2332138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide.
    Cosi C; Marien M
    Brain Res; 1998 Oct; 809(1):58-67. PubMed ID: 9795136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mechanism of action of MPTP and MPP+ on endogenous dopamine release from the rat corpus striatum superfused in vitro.
    Chang GD; Ramirez VD
    Brain Res; 1986 Mar; 368(1):134-40. PubMed ID: 3485463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FGF-2 modulates dopamine and dopamine-related striatal transmitter systems in the intact and MPTP-lesioned mouse.
    Otto D; Unsicker K
    Eur J Neurosci; 1993 Jul; 5(7):927-32. PubMed ID: 7506615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation by dopamine uptake blockers of the inhibitory effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and some of its analogs on NADH-linked metabolism in mouse neostriatal slices.
    Ofori S; Heikkila RE; Nicklas WJ
    J Pharmacol Exp Ther; 1989 Oct; 251(1):258-66. PubMed ID: 2571719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
    Chan P; Langston JW; Di Monte DA
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new in vitro approach for investigating the MPTP effect on DA uptake.
    Barc S; Page G; Fauconneau B; Barrier L; Huguet F
    Neurochem Int; 2001 Mar; 38(3):243-8. PubMed ID: 11099783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurochemical evidence for agmatine modulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity.
    Gilad GM; Gilad VH; Finberg JP; Rabey JM
    Neurochem Res; 2005; 30(6-7):713-9. PubMed ID: 16187208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial toxins in models of neurodegenerative diseases. II: Elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment.
    Smith TS; Trimmer PA; Khan SM; Tinklepaugh DL; Bennett JP
    Brain Res; 1997 Aug; 765(2):189-97. PubMed ID: 9313891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-related decrease in apomorphine modulation of acetylcholine release from rat striatal slices.
    Thompson JM; Makino CL; Whitaker JR; Joseph JA
    Brain Res; 1984 May; 299(1):169-73. PubMed ID: 6722565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) on monoamine neurotransmitters in mouse brain & heart.
    Wallace RA; Boldry R; Schmittgen T; Miller D; Uretsky N
    Life Sci; 1984 Jul; 35(3):285-91. PubMed ID: 6146909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ascorbic acid reduces the dopamine depletion induced by MPTP.
    Wagner GC; Jarvis MF; Carelli RM
    Neuropharmacology; 1985 Dec; 24(12):1261-2. PubMed ID: 3879339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+.
    Sun CJ; Johannessen JN; Gessner W; Namura I; Singhaniyom W; Brossi A; Chiueh CC
    J Neural Transm; 1988; 74(2):75-86. PubMed ID: 3266233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of [3H]MPP+ uptake in dopaminergic neurons of mouse: regional effects of MPTP neurotoxicity.
    Sershen H; Mason MF; Debler EA; Lajtha A
    Eur J Pharmacol; 1986 Jul; 126(3):337-9. PubMed ID: 3489627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced dopamine D2 receptor hypersensitivity in the mouse is transient.
    Peroutka SJ; DeLanney L; Irwin I; Ison PJ; Ricaurte G; Schlegel JR; Langston JW
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):163-71. PubMed ID: 3875136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and related compounds on the uptake of [3H]3,4-dihydroxyphenylethylamine and [3H]5-hydroxytryptamine in neostriatal synaptosomal preparations.
    Heikkila RE; Youngster SK; Manzino L; Cabbat FS; Duvoisin RC
    J Neurochem; 1985 Jan; 44(1):310-3. PubMed ID: 3871120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the interaction of roxindole with brain monoamine oxidases and dopaminergic neurones in vitro and in vivo.
    Seyfried CA; Adam G
    Pharmacol Toxicol; 1994 Jun; 74(6):314-20. PubMed ID: 7937563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
    Harik SI; Schmidley JW; Iacofano LA; Blue P; Arora PK; Sayre LM
    J Pharmacol Exp Ther; 1987 May; 241(2):669-76. PubMed ID: 2437293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neurochemical and clinical effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in small animals.
    Donnan GA; Kaczmarczyk SJ; Solopotias T; Rowe P; Kalnins RM; Vajda FJ; Mendelsohn FA
    Clin Exp Neurol; 1986; 22():155-64. PubMed ID: 3495376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.